Wei Wei

17.5k total citations · 5 hit papers
474 papers, 13.7k citations indexed

About

Wei Wei is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Wei Wei has authored 474 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Molecular Biology, 122 papers in Immunology and 90 papers in Cancer Research. Recurrent topics in Wei Wei's work include Rheumatoid Arthritis Research and Therapies (46 papers), Receptor Mechanisms and Signaling (41 papers) and MicroRNA in disease regulation (38 papers). Wei Wei is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (46 papers), Receptor Mechanisms and Signaling (41 papers) and MicroRNA in disease regulation (38 papers). Wei Wei collaborates with scholars based in China, Saint Kitts and Nevis and United States. Wei Wei's co-authors include Lingling Zhang, Heinrich Körner, Yan Chang, Qingtong Wang, A. Bruce Lyons, Shanshan Hu, Jocelyn M. Darby, Xuezhi Yang, Wu‐Yi Sun and Hua Wang and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Wei Wei

456 papers receiving 13.5k citations

Hit Papers

Absence of Tumor Necrosis Factor Supports Alternative Act... 2018 2026 2020 2023 2018 2019 2019 2022 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Wei China 57 6.8k 2.9k 2.3k 2.0k 1.4k 474 13.7k
Fuu‐Jen Tsai Taiwan 55 5.8k 0.8× 1.4k 0.5× 1.2k 0.5× 1.4k 0.7× 1.0k 0.7× 520 13.9k
Qizhi Yao United States 59 4.8k 0.7× 1.4k 0.5× 1.5k 0.7× 1.8k 0.9× 376 0.3× 215 11.8k
Karolien De Bosscher Belgium 54 4.6k 0.7× 2.7k 0.9× 2.1k 0.9× 1.9k 0.9× 391 0.3× 140 10.9k
Athanasios G. Papavassiliou Greece 68 8.0k 1.2× 1.6k 0.5× 2.7k 1.1× 3.2k 1.6× 1.3k 0.9× 488 17.5k
Tao Liu China 63 10.1k 1.5× 1.8k 0.6× 5.0k 2.1× 2.3k 1.2× 1.1k 0.8× 502 16.2k
Ferdinando Nicoletti Italy 62 4.5k 0.7× 3.5k 1.2× 976 0.4× 1.7k 0.9× 886 0.6× 322 11.8k
Geert Loo Belgium 64 9.0k 1.3× 6.7k 2.3× 3.3k 1.4× 1.9k 0.9× 483 0.3× 148 16.9k
Thomas G. Cotter Ireland 64 11.8k 1.7× 2.6k 0.9× 1.8k 0.8× 2.6k 1.3× 331 0.2× 244 18.4k
Richard D. Ye United States 65 7.2k 1.1× 4.1k 1.4× 1.4k 0.6× 1.6k 0.8× 254 0.2× 245 13.4k
Zheng Dong United States 89 12.9k 1.9× 2.2k 0.8× 3.6k 1.6× 2.2k 1.1× 310 0.2× 383 26.3k

Countries citing papers authored by Wei Wei

Since Specialization
Citations

This map shows the geographic impact of Wei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wei more than expected).

Fields of papers citing papers by Wei Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wei. The network helps show where Wei Wei may publish in the future.

Co-authorship network of co-authors of Wei Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wei. A scholar is included among the top collaborators of Wei Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wei. Wei Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Zhuo, Rui Wang, Wei Wei, et al.. (2025). A novel role for the regulatory NRP1 in immune and inflammatory reactions during radiation-induced lung injury. International Journal of Biological Macromolecules. 308(Pt 1). 142307–142307. 1 indexed citations
2.
Ma, Tingxuan, Jing Ma, Yipin Wang, et al.. (2025). Targeting BACH1/PSPH axis suppresses bladder cancer progression and gemcitabine resistance by downregulating S100A2 expression. Biochemical Pharmacology. 241. 117182–117182.
4.
5.
Wei, Wei, et al.. (2024). Renal transplantation in patients with cryopyrin-associated periodic syndrome: A case report and literature review. International Immunopharmacology. 146. 113879–113879. 1 indexed citations
6.
Han, Dafei, et al.. (2024). Inhibition of GRK2 ameliorates the pristane-induced mouse SLE model by suppressing plasma cells differentiation. International Immunopharmacology. 138. 112557–112557. 5 indexed citations
7.
Wang, Xinming, Huihui Wang, Wenming Hong, et al.. (2024). Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis. Arthritis & Rheumatology. 76(6). 845–856. 9 indexed citations
8.
Wei, Wei, Feifei Wu, Jingxia Li, et al.. (2024). FGF21 overexpression alleviates VSMC senescence in diabetic mice by modulating the SYK-NLRP3 inflammasome-PPARγ-catalase pathway. Acta Biochimica et Biophysica Sinica. 56(6). 892–904.
9.
Wang, Ziying, Pingping Gao, Ling Li, et al.. (2023). Dextran sulfate sodium-induced gut microbiota dysbiosis aggravates liver injury in mice with S100-induced autoimmune hepatitis. Immunology Letters. 263. 70–77. 4 indexed citations
10.
Yu, Jun, et al.. (2023). Role of cyclosporin A in the treatment of kidney disease and nephrotoxicity. Toxicology. 492. 153544–153544. 18 indexed citations
11.
Zhao, Han, Dan Peng, Zhengwang Chen, et al.. (2023). Novel soybean polypeptide dglycin alleviates atherosclerosis in apolipoprotein E-deficient mice. International Journal of Biological Macromolecules. 251. 126347–126347. 5 indexed citations
12.
Chen, Tingting, Xiuqin Li, Nan Li, et al.. (2023). β-arrestin2 deficiency ameliorates S-100-induced autoimmune hepatitis in mice by inhibiting infiltration of monocyte-derived macrophage and attenuating hepatocyte apoptosis. Acta Pharmacologica Sinica. 44(10). 2048–2064. 8 indexed citations
13.
Liu, Yunxiao, Xinge Zhang, Wei Cao, et al.. (2023). Xanthatin induce DDP‐resistance lung cancer cells apoptosis through regulation of GLUT1 mediated ROS accumulation. Drug Development Research. 84(6). 1266–1278. 6 indexed citations
14.
Chen, Yizhao, Hanze Liu, Yu Chen, et al.. (2023). The application of HER2 and CD47 CAR-macrophage in ovarian cancer. Journal of Translational Medicine. 21(1). 654–654. 59 indexed citations
15.
Wei, Wei, et al.. (2022). Study on Electrochemical Corrosion and CMP of GaN in Different Oxidation Systems. ECS Journal of Solid State Science and Technology. 11(3). 34002–34002. 13 indexed citations
16.
Cui, Hong‐Yong, Wei Wei, Xin Fu, et al.. (2022). PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression. Cancer Communications. 42(8). 750–767. 16 indexed citations
17.
Yang, Mei & Wei Wei. (2019). SNHG16: A Novel Long-Non Coding RNA in Human Cancers. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Chen, Jingyu, Huaxun Wu, Qingtong Wang, et al.. (2014). Ginsenoside Metabolite Compound K Alleviates Adjuvant-Induced Arthritis by Suppressing T Cell Activation. Inflammation. 37(5). 1608–1615. 46 indexed citations
19.
Wang, Chun, et al.. (2012). Pharmacokinetics of paeoniflorin microemulsion after repeated dosing in rats with adjuvant arthritis.. PubMed. 67(12). 997–1001. 15 indexed citations
20.
Chen, Qun & Wei Wei. (2005). New Therapeutic Approaches for Rheumatoid Arthritis. Assay and Drug Development Technologies. 3(3). 329–337.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026